v3.26.3
BALANCE SHEET COMPONENTS
9 Months Ended
Aug. 31, 2026
Balance Sheet Related Disclosures [Abstract]  
BALANCE SHEET COMPONENTS BALANCE SHEET COMPONENTS:
Cash, cash equivalents, cash held for sale, restricted cash and restricted cash held for sale:

The following table provides a reconciliation of cash, cash equivalents, cash held for sale, restricted cash and restricted cash held for sale reported within the consolidated balance sheets to the total of the same amounts shown in the consolidated statements of cash flows:
As of
August 31, 2026
August 31, 2025
Cash and cash equivalents
$
244,692 
$
350,259 
Cash held for sale
11,133 
— 
Restricted cash included in other current assets
33,474 
188,227 
Restricted cash held for sale
165,480 
— 
Cash, cash equivalents, cash held for sale, restricted cash and restricted cash held for sale
$
454,779 
$
538,486 
Restricted cash and restricted cash held for sale balances relate primarily to funds held for clients, restrictions placed on cash deposits by banks as collateral for the issuance of bank guarantees and the terms of a government grant, and letters of credit for leases. Of the restricted cash balance and the restricted cash held for sale balance, an aggregate of $190,722 and $187,139 related to funds held for clients as of August 31, 2026 and November 30, 2025, respectively. As of August 31, 2026 and November 30, 2025, the Company has a corresponding current liability recorded in current liabilities held for sale and other accrued liabilities on the consolidated balance sheet related to these funds.
Accounts receivable, net:
Accounts receivable, net is comprised of the following as of August 31, 2026 and November 30, 2025:
As of
August 31, 2026
November 30, 2025
Billed accounts receivable
$
1,085,321 
$
1,102,601 
Unbilled accounts receivable
908,356 
913,863 
Less: Allowance for credit losses
(23,829)
(17,443)
Accounts receivable, net
$
1,969,848 
$
1,999,021 
Allowance for credit losses:
Presented below is a progression of the allowance for credit losses:
Three Months Ended
Nine Months Ended
August 31, 2026
August 31, 2025
August 31, 2026
August 31, 2025
Balance at beginning of period
$
22,640 
$
19,561 
$
17,443 
$
14,307 
Net additions
1,278 
549 
7,384 
5,467 
Write-offs and reclassifications
(89)
(724)
(998)
(388)
Balance at end of period
$
23,829 
$
19,386 
$
23,829 
$
19,386 

Property and equipment, net:
The following table summarizes the carrying amounts and related accumulated depreciation for property and equipment as of August 31, 2026 and November 30, 2025:
As of
August 31, 2026
November 30, 2025
Land
$
19,388 
$
28,391 
Equipment, computers, and software
1,008,043 
969,841 
Furniture and fixtures
176,843 
172,154 
Buildings, building improvements, and leasehold improvements
749,492 
704,074 
Construction-in-progress
30,263 
39,098 
Total property and equipment, gross
$
1,984,029 
$
1,913,558 
Less: Accumulated depreciation
(1,285,913)
(1,178,008)
Property and equipment, net
$
698,116 
$
735,550 
Shown below are the countries where 10% or more and other significant concentrations of the Company’s property and equipment, net are located as of August 31, 2026 and November 30, 2025:
As of
August 31, 2026
November 30, 2025
Property and equipment, net:
Philippines
$
95,533 
$
105,475 
United States
77,518 
93,773 
India
68,214 
57,585 
France
46,928 
56,386 
Others
409,923 
422,331 
Total
$
698,116 
$
735,550 
Goodwill:
The Company tests goodwill for impairment annually on the first day of its fourth fiscal quarter and at other times if events have occurred or circumstances exist that indicate the carrying value of goodwill may no longer be recoverable. Goodwill is tested for impairment at the reporting unit level. The Company has one reporting unit, which is the consolidated company.

During the third quarter of fiscal 2026, the Company experienced a sustained decrease in the market price of its common stock resulting in the market capitalization being significantly less than the carrying value of the reporting unit. This led the Company to determine that triggering events occurred, and a quantitative goodwill impairment assessment was performed during the three months ended August 31, 2026.

The quantitative impairment assessment consisted of estimating the fair value of the Company’s reporting unit using an equal weighting of the income and market valuation approaches. The resulting fair value estimate was evaluated for reasonableness through a reconciliation to the Company's market capitalization. The income approach applied a fair value methodology to our reporting unit based on discounted cash flows. This analysis requires significant judgments and assumptions, including estimation of our future cash flows, which is dependent on internally developed forecasts, including future levels of revenue growth, and adjusted earnings before interest, taxes, depreciation, and amortization (“EBITDA”) margin, and determination of a weighted average cost of capital. We also applied a market approach. Under the market approach, we utilized a guideline public company method, which involves calculating valuation multiples based on financial data from comparable publicly traded companies and considerations of recent transactions in the technology industry. Multiples derived from these companies and transactions provide an indication of how much a knowledgeable investor in the marketplace would be willing to pay for a company. These multiples are then applied to the financial data for our reporting unit to arrive at an indication of fair value. The market multiple was applied to adjusted EBITDA. Determining the fair value of the Company’s reporting unit required significant judgments, estimates and assumptions. The Company believes these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions, and estimates that are used in the impairment testing for goodwill, including discount and tax rates or future cash flow projections, could result in significantly different estimates of fair value. As a result of these factors, and the impact of macroeconomic conditions, goodwill for our single reporting unit may be more susceptible to impairment risk.

As a result of the quantitative analysis performed, the carrying value of the Company’s reporting unit was determined to exceed its fair value, resulting in a non-cash goodwill impairment charge of $1,050,000. This charge was recorded within the impairment charge caption of the consolidated statement of operations for the three and nine months ended August 31, 2026. No subsequent impairment indicators were identified. No goodwill impairment charges were recognized during the three and nine months ended August 31, 2025.

The balance of goodwill immediately preceding the impairment charge was $3,686,667. The goodwill impairment charge is nondeductible for tax purposes.
The Company is required to provide additional disclosures about fair value measurements as part of the consolidated financial statements for each major category of assets and liabilities measured at fair value on a non-recurring basis (including impairment assessments). The goodwill impairment was valued using Level 3 fair value inputs, which are unobservable by nature, and included internal estimates of future cash flows (income approach). Significant increases (decreases) in any of those unobservable inputs in isolation would result in a significantly higher (lower) fair value measurement.

The following table summarizes the changes in the Company’s goodwill for the nine months ended August 31, 2026 and August 31, 2025:
Nine Months Ended
August 31, 2026
August 31, 2025
Balance at beginning of period
$
3,671,746 
$
4,986,967 
Acquisition and acquisition-related adjustments
(154)
2,353 
Assets held for sale
(9,621)
— 
Impairment charge
(1,050,000)
— 
Foreign exchange translation
24,696 
202,245 
Balance at end of period
$
2,636,667 
$
5,191,565 
Intangible assets, net:
The following tables summarize the carrying amounts and related accumulated amortization for intangible assets as of August 31, 2026 and November 30, 2025:
As of August 31, 2026
As of November 30, 2025
Gross amounts
Accumulated amortization
Net amounts
Gross amounts
Accumulated amortization
Net amounts
Customer relationships
$
3,736,378 
$
(2,092,597)
$
1,643,781 
$
3,736,591 
$
(1,822,119)
$
1,914,472 
Technology
79,741 
(74,640)
5,101 
79,603 
(64,089)
15,514 
Trade names
123,738 
(121,220)
2,518 
123,484 
(93,132)
30,352 
Non-compete agreements
2,200 
(2,200)
— 
2,200 
(2,200)
— 
Total
$
3,942,057 
$
(2,290,657)
$
1,651,400 
$
3,941,878 
$
(1,981,540)
$
1,960,338 
Estimated future amortization expense of the Company’s intangible assets is as follows:
Fiscal years ending November 30,
2026 (remaining three months)
$
85,616 
2027
296,964 
2028
251,717 
2029
209,526 
2030
177,582 
Thereafter
629,995 
Total
$
1,651,400 
Accumulated other comprehensive loss:
The components of accumulated other comprehensive loss (“AOCL”), net of taxes, were as follows:
Three Months Ended August 31, 2026 and 2025
Unrecognized gains (losses) on
 defined benefit plan, net of taxes
Unrealized gains (losses) on
 hedges, net of taxes
Foreign currency translation
adjustments and other, net of taxes
Total
Balances at May 31, 2025
$
(4,166)
$
5,740 
$
(224,606)
$
(223,032)
Other comprehensive income (loss) before reclassification     
(14)
(13,074)
27,548 
14,460 
Reclassification of gains from other comprehensive income (loss)     
— 
(545)
— 
(545)
Balances at August 31, 2025
$
(4,180)
$
(7,879)
$
(197,058)
$
(209,117)
Balances at May 31, 2026
$
(20,401)
$
(40,133)
$
(272,411)
$
(332,945)
Other comprehensive income (loss) before reclassification     
1,409 
6,281
39,254 
46,944 
Reclassification of losses from other comprehensive income (loss)     
476 
9,621
— 
10,097 
Balances at August 31, 2026
$
(18,516)
$
(24,231)
$
(233,157)
$
(275,904)
Nine Months Ended August 31, 2026 and 2025
Unrecognized gains (losses) on
 defined benefit plan, net of taxes
Unrealized gains (losses) on
 hedges, net of taxes
Foreign currency translation
adjustments, net of taxes
Total
Balances at November 30, 2024
$
(5,283)
$
(25,881)
$
(383,149)
$
(414,313)
Other comprehensive income (loss) before reclassification
1,103 
14,375 
186,091 
201,569 
Reclassification of losses from other comprehensive income (loss)
— 
3,627
— 
3,627 
Balances at August 31, 2025
$
(4,180)
$
(7,879)
$
(197,058)
$
(209,117)
Balances at November 30, 2025
$
(1,581)
$
(22,641)
$
(228,240)
$
(252,462)
Other comprehensive income (loss) before reclassification
(20,272)
(23,825)
(4,917)
(49,014)
Reclassification of losses from other comprehensive income (loss)
3,337 
22,235
— 
25,572 
Balances at August 31, 2026
$
(18,516)
$
(24,231)
$
(233,157)
$
(275,904)
Refer to Note 6—Derivative Instruments for the location of gains and losses on cash flow hedges reclassified from other accumulated other comprehensive loss to the consolidated statements of operations. Reclassifications of amortization of actuarial (gains) losses of defined benefit plans are recorded in “Other expense (income), net” in the consolidated statement of operations.